FAQs

Senores Pharmaceuticals operates in Pharmaceutical and developing and manufacturing a wide range of pharmaceutical products. The Issue would be listed on MainBoard. The registrar of the Issue is Link Intime India Private Limited. The IPO type of Senores Pharmaceuticals is Book building Process and Object of issue is

• Funding the capital expenditure requirements by investment in of one of their Subsidiaries, Havix Group, Inc. d/b/aAavis Pharmaceuticals(“Havix”), for setting up a manufacturing facility for the production of sterile injections in our Atlanta Facility;
• Re-payment/pre-payment, in full or in part, of certain borrowings availed by the Company and Subsidiaries, namely, Havix, Ratnatris Pharmaceutical Private Limited (“Ratnatris”) and Senores Pharmaceuticals Inc. (“SPI”)
• Funding the working capital requirements of the Company and their Subsidiaries, namely, SPI and Ratnatris
• Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes

Merchant Banker of Senores Pharmaceuticals IPO is Ambit Private Limited , Equirus Capital Private Limited , Nuvama Wealth Management Limited

The DRHP (Draft Red Herring Prospectus) of Senores Pharmaceuticals IPO was filed on 26 Jul 2024.

No, Senores Pharmaceuticals IPO is not yet listed. See other upcoming MainBoard IPOs here.

The IPO open date and IPO close date of Senores Pharmaceuticals are not available now. You can apply in Senores Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application can be done through net banking of your bank account. UPI IPO application is also offered by brokers, though they don't handle any banking services.